Pfizer CEO Albert Bourla supports Trump administration at PhRMA Forum, while CDC postpones vaccine advisory meeting. Atomwise names Steve Worland as CEO, and Biogen licenses Dravet drug.

Tang Capital's Concentra Biosciences offers to buy Acelyrin for $3/share, challenging planned Alumis merger. Concentra would ...

A pair of investors will acquire bluebird bio in a deal worth only $29 million upfront after the gene therapy maker ran out ...

Pfizer ends commercialization of Beqvez hemophilia B gene therapy. CEO Kim Phelan of Coalition for Hemophilia B expresses ...

The FDA said Friday that the shortage of semaglutide, the main ingredient in Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy, ...

As he was testing new antivirals to halt a future pandemic, John Chodera encountered an unlikely set of new problems that ...

Eli Lilly has amassed a stockpile of soon-to-be-launched drugs and related materials, primarily its oral GLP-1 candidate ...

Spot­light Ther­a­peu­tics, a start­up with a bold vi­sion for de­liv­er­ing CRISPR ther­a­pies in­to the body with­out the ...

A meet­ing of CDC vac­cine ad­vi­sors has been post­poned, ac­cord­ing to a se­nior HHS of­fi­cial. “The ACIP meet­ing will ...

Over 500 pharma executives, lobbyists, consultants and other industry members gathered a couple miles from the White House on ...

Latigo Biotherapeutics, a non-opioid pain biotech looking to ride the waves created by Vertex Pharmaceuticals' pain drug ...

A month af­ter Bio­gen sig­naled plans to shift its at­ten­tion to “ ex­ter­nal op­por­tu­ni­ties ,” it de­liv­ered on that ...